Search Results 6421-6430 of 34844 for oral
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors. Cancers (Basel). 2024 Mar 13; 16 (6)
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating the ...
2003. Outstanding Oral Presentation awardNational Cancer Institute, National Institutes of Health, National Institutes of Health. 2001. Dean's Honor List ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic Surgery · Proton Beam Therapy Program ...
Immunosuppressed patient (Use of immunosuppressive medications in past 90 days (Examples include: oral or IV corticosteroids (topical creams or nasal sprays ...
- Known allergy or intolerance to oral vancomycin. - Concomitant participation or participation within 14 days or 5 half-lives of another investigational ...
All patients must provide written or oral informed consent to participate in the registry depending on the local regulations. Patients having received a ...
If you have never taken risperidone, your doctor will first give you an oral form of this medicine before starting treatment with Perseris™, Risperdal Consta®, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.